FGF21-Mediated Improvements in Glucose Clearance Require Uncoupling Protein 1

Cell Reports

Volumn 13, Issue 8, 2015, Pages 1521-1527

  Kwon, Michelle M ^a   O'Dwyer, Shannon M ^a   Baker, Robert K ^a   Covey, Scott D ^a   Kieffer, Timothy J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GLUCOSE; UNCOUPLING PROTEIN 1; FIBROBLAST GROWTH FACTOR; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; BONE DENSITY; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIET INDUCED OBESITY; FAT MASS; GENE; GENE DELETION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HYDRODYNAMICS BASED TRANSFECTION; IMMUNOREACTIVITY; LEAN BODY WEIGHT; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THERMOGENESIS; UCP1 GENE; WEIGHT REDUCTION; ANIMAL; ENERGY METABOLISM; KNOCKOUT MOUSE; METABOLISM; OBESITY; PHYSIOLOGY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BODY WEIGHT; ENERGY METABOLISM; FIBROBLAST GROWTH FACTORS; GLUCOSE; ION CHANNELS; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; OBESITY; THERMOGENESIS;

EID: 84952876074     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.10.021     Document Type: Article

References (13)

1. Coskun T., Bina H.A., Schneider M.A., Dunbar J.D., Hu C.C., Chen Y., Moller D.E., Kharitonenkov A. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 2008, 149:6018-6027.
2. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., Kuo F.C., Palmer E.L., Tseng Y.H., Doria A., et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 2009, 360:1509-1517.
3. Emanuelli B., Vienberg S.G., Smyth G., Cheng C., Stanford K.I., Arumugam M., Michael M.D., Adams A.C., Kharitonenkov A., Kahn C.R. Interplay between FGF21 and insulin action in the liver regulates metabolism. J. Clin. Invest. 2014, 124:515-527.
4. Fisher F.M., Chui P.C., Antonellis P.J., Bina H.A., Kharitonenkov A., Flier J.S., Maratos-Flier E. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010, 59:2781-2789.
5. Fisher F.M., Kleiner S., Douris N., Fox E.C., Mepani R.J., Verdeguer F., Wu J., Kharitonenkov A., Flier J.S., Maratos-Flier E., Spiegelman B.M. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012, 26:271-281.
6. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., Sandusky G.E., Hammond L.J., Moyers J.S., Owens R.A., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 2005, 115:1627-1635.
7. Kim J.H., Bae K.H., Choi Y.K., Go Y., Choe M., Jeon Y.H., Lee H.W., Koo S.H., Perfield J.W., Harris R.A., et al. Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function. Diabetes Obes. Metab. 2015, 17:161-169.
8. Samms R.J., Smith D.P., Cheng C.C., Antonellis P.P., Perfield J.W., Kharitonenkov A., Gimeno R.E., Adams A.C. Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1. Cell Rep. 2015, 11:991-999.
9. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., Schrauwen P., Teule G.J. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 2009, 360:1500-1508.
10. Véniant M.M., Sivits G., Helmering J., Komorowski R., Lee J., Fan W., Moyer C., Lloyd D.J. Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue. Cell Metab. 2015, 21:731-738.
11. Wei W., Dutchak P.A., Wang X., Ding X., Wang X., Bookout A.L., Goetz R., Mohammadi M., Gerard R.D., Dechow P.C., et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. Proc. Natl. Acad. Sci. USA 2012, 109:3143-3148.
12. Xu J., Lloyd D.J., Hale C., Stanislaus S., Chen M., Sivits G., Vonderfecht S., Hecht R., Li Y.S., Lindberg R.A., et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 2009, 58:250-259.
13. Xu J., Stanislaus S., Chinookoswong N., Lau Y.Y., Hager T., Patel J., Ge H., Weiszmann J., Lu S.C., Graham M., et al. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1105-E1114.